Generics

Filter

Current filters:

None

Popular Filters

1126 to 1150 of 1234 results

Irish drugmakers argue against ESRI Budget Perspectives (2012) proposals

24-10-2011

Budget Perspectives 2012, a paper published last week by the Economic and Social Research Institute (ESRI),…

EuropeGenericsHealthcarePharmaceuticalPricing

EU Commission opens antitrust proceedings against Johnson & Johnson and Novartis

24-10-2011

The European Commission revealed last Friday that it has opened an antitrust investigation, on its own…

EuropefentanylGenericsJohnson & JohnsonLegalNeurologicalNovartisPatentsPharmaceutical

On the issue of delaying generics, South Africa’s pharma market not comparable with the USA, expert says

23-10-2011

A recent report by the US competition authority, the Federal Trade Commission, on the short and long-term…

GenericsPatentsRest of the World

Generics to constrain growth of Parkinson’s disease drug market through 2020

23-10-2011

Over the next decade, the Parkinson’s disease (PD) drug market in the leading countries (USA, France,…

GenericsGlobalMarkets & MarketingNeurologicalPharmaceutical

Prasco selected as Eli Lilly authorized generics partner for Zyprexa

20-10-2011

Privately-held US drugmaker Prasco Laboratories says it has signed a marketing and distribution agreement…

Eli LillyGenericsMarkets & MarketingNeurologicalNorth AmericaPrasco LaboratoriesZyprexa

Sun Pharma offers to acquire remainder of Taro shares

20-10-2011

Indian drugmaker Sun Pharmaceuticals (SUN: BO) has proposed to acquire the remaining shares of Israel-based…

GenericsMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

Mylan settles with Warner Chilcott over Femcon

19-10-2011

US generic drugmaker Mylan (Nasdaq: MYL) said yesterday that it, along with Famy Care, has entered into…

Femcon FeGenericsLegalMylan LaboratoriesNorth AmericaPatentsRespiratory and PulmonaryWarner Chilcott

US Senators Kohl and Grassley urge “Super Committee” to encourage generic competition

19-10-2011

As the USA’s Joint Select Committee on Deficit Reduction - dubbed the “Super Committee”…

GenericsHealthcareNorth AmericaPatentsPharmaceuticalPolitics

Second Indian generics deal for SA’s Litha, this one with Micro Labs

18-10-2011

In a second deal with an Indian drugmaker, South Africa’s Litha Healthcare has signed an exclusive…

Asia-PacificGenericsLicensingLitha HealthcareRest of the World

Canada would lose out on generic industry investment by adopting EU pharma proposals, warns CGPA

12-10-2011

Canada could face a loss of jobs and investment in its R&D intensive and fast-growing generic pharmaceutical…

GenericsNorth AmericaPatentsPharmaceuticalResearch

EGA names new president, who aims to increase access to generic medicines

12-10-2011

Meeting yesterday in Warsaw, Poland, the European Generic medicines Association’s (EGA) board announced…

EuropeGenericsManagementPricing

European Commission wants clearer rules for patient information on prescription medicines

12-10-2011

With the aim of empowering patients, the European Commission yesterday adopted revised proposals clarifying…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulation

Govt officials and regulators in India consult on stopping spurious drugs

05-10-2011

A national consultation meeting was held in India this week to build consensus on the methodology needed…

Asia-PacificGenericsPharmaceuticalPoliticsRegulation

Hikma enters Moroccan market via $111 million controlling stake in Promopharm

05-10-2011

Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has acquired 63.9% of Promopharm (Societe…

GenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalPromopharmRest of the World

Daiichi Sankyo extends reach in Italy, with Ranbaxy to market its products

05-10-2011

The Italian subsidiaries of Japanese drug major Daiichi Sankyo (TYO: 4568) and its majority-owned India-based…

Cardio-vascularDaiichi SankyoEuropeGenericsMarkets & MarketingRanbaxy Laboratories

Key considerations for successful biosimilar development viewed by Quintiles

03-10-2011

Regulatory and commercial considerations are the primary drivers for successful biosimilar clinical development,…

BiotechnologyGenericsGlobalQuintilesRegulationResearch

1126 to 1150 of 1234 results

Back to top